Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Net Income (2021 - 2025)

Senti Biosciences (SNTI) has 4 years of Net Income data on record, last reported at -$16.8 million in Q3 2025.

  • For Q3 2025, Net Income changed N/A year-over-year to -$16.8 million; the TTM value through Sep 2025 reached -$49.3 million, down 176017.86%, while the annual FY2023 figure was $12.3 million, 244.51% up from the prior year.
  • Net Income reached -$16.8 million in Q3 2025 per SNTI's latest filing, down from -$16.5 million in the prior quarter.
  • Across five years, Net Income topped out at $21.7 million in Q3 2023 and bottomed at -$21.7 million in Q2 2022.
  • Average Net Income over 4 years is -$6.2 million, with a median of -$4.4 million recorded in 2023.
  • Peak YoY movement for Net Income: plummeted 997692.87% in 2022, then skyrocketed 1028.2% in 2023.
  • A 4-year view of Net Income shows it stood at -$3.9 million in 2021, then crashed by 306.16% to -$15.7 million in 2022, then skyrocketed by 99.82% to -$28000.0 in 2023, then plummeted by 59835.71% to -$16.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$16.8 million in Q3 2025, -$16.5 million in Q2 2025, and -$16.0 million in Q1 2025.